Insider Transactions Reported by 18 Insiders of RVL Pharmaceuticals plc

Location
Bridgewater, NJ

There are no Buy or Sell transactions made by insiders since 09 Feb 2025

RVL Pharmaceuticals plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Avista Healthcare Partners, L.P. 10%+ Owner $772,632 08 Aug 2022
Athyrium Opportunities IV Acquisition 2 LP 10%+ Owner $201,290 08 Aug 2022
Altchem Ltd 10%+ Owner $191,048 19 Oct 2023
Foundation Harsaul 10%+ Owner $154,162 19 Oct 2023
BRIAN A. MARKISON Chief Executive Officer, Director $92,852 08 Aug 2022
James Schaub EVP and COO $16,375 18 May 2023
Christopher Klein General Counsel & Secretary $5,634 18 May 2023
Andrew J. Einhorn Chief Financial Officer $5,127 24 Jan 2022
Tina Marie deVries EVP, Research & Development $4,248 18 May 2022
FRED G. WEISS Director $3,696 27 Aug 2021
Alisa Lask Director $3,512 10 Aug 2023
GREGORY L. COWAN Director $2,810 05 Jul 2023
Michael J. DeBiasi Director $1,248 05 Jul 2023
Michael DePetris Principal Accounting Officer 18 Apr 2022
David Burgstahler Director, 10%+ Owner 27 Jan 2023
Avista Capital Partners III GP, L.P. 10%+ Owner 27 Jan 2023
Sriram Venkataraman Director, 10%+ Owner 27 Jan 2023
Avista Healthcare Partners GP, Ltd. 10%+ Owner 15 Aug 2023

Recent Insider Transactions by Companies or Individuals for RVL Pharmaceuticals plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.